Request Deal Involvement

Carlyle and Warburg Pincus led a $123m series D round in Abbisko Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Latham & Watkins

legal advisors

Latham & Watkins

or

Principals

SAGE PARTNERS

bidder

SAGE PARTNERS

ABBISKO THERAPEUTICS

target

ABBISKO THERAPEUTICS

THE CARLYLE GROUP

bidder

THE CARLYLE GROUP

WARBURG PINCUS LLC

bidder

WARBURG PINCUS LLC

JANCHOR CAPITAL

bidder

JANCHOR CAPITAL

GREATER BAY AREA HOMELAND INVESTMENTS

bidder

GREATER BAY AREA HOMELAND INVESTMENTS

LILLY ASIA VENTURES

bidder

LILLY ASIA VENTURES

TEMASEK HOLDINGS LIMITED

bidder

TEMASEK HOLDINGS LIMITED

QIMING VENTURE PARTNERS

bidder

QIMING VENTURE PARTNERS

HANKANG CAPITAL

bidder

HANKANG CAPITAL

CHINA INTERNATIONAL CAPITAL CORPORATION (CICC)

bidder

CHINA INTERNATIONAL CAPITAL CORPORATION (CICC)

ORBIMED ADVISORS LLC

bidder

ORBIMED ADVISORS LLC

LAKE BLEU CAPITAL

bidder

LAKE BLEU CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Carlyle and Warburg Pincus led a $123m series D round in Abbisko Therapeutics.